The latest price target for Charles River (NYSE:CRL) was reported by Morgan Stanley on June 17, 2026. The analyst firm set a price target for $220.00 expecting CRL to rise to within 12 months (a possible 20.65% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for Charles River (NYSE:CRL) was provided by Morgan Stanley, and Charles River upgraded their overweight rating.

The last upgrade for Charles River Laboratories International Inc happened on June 17, 2026 when Morgan Stanley raised their price target to $220. Morgan Stanley previously had an equal-weight for Charles River Laboratories International Inc.

The last downgrade for Charles River Laboratories International Inc happened on March 21, 2025 when Goldman Sachs changed their price target from $190 to $170 for Charles River Laboratories International Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Charles River, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Charles River was filed on June 17, 2026 so you should expect the next rating to be made available sometime around June 17, 2027.

While ratings are subjective and will change, the latest Charles River (CRL) rating was a upgraded with a price target of $185.00 to $220.00. The current price Charles River (CRL) is trading at is $182.34, which is out of the analyst’s predicted range.